Seegene develops PCR test to detect monkeypox virus


Assay targets monkeypox virus and can deliver results in 90 minutes

Company swiftly rolls out product using its automated assay development system

Seegene will strive to make accurate tests for emerging viruses to help prevent future pandemics

Seegene Inc., South Korea’s leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company’s AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.

the monkeypox virus is an “evolving health threat that requires collective attention and coordinated action,” calling on member states to step up surveillance, contact tracing and testing. The monkeypox virus has been detected in over 50 nations, with South Korea confirming its first case last week. The strain currently circulating in the Northern Hemisphere has an estimated fatality rate of between 3-6 percent and is considered especially dangerous for children and those with weak immune systems.

The World Health Organization says

As with many infectious diseases, accurate diagnosis is crucial as treatments are more effective in the early stages of infection. This makes timely PCR testing vital, especially for individuals with a suspected case, as the incubation period for the monkeypox infection ranges between five to 21 days.

The Novaplex™ MPXV Assay can identify positive cases of the monkeypox virus in 90 minutes. The company swiftly developed the product to help curb the worldwide spread. Seegene plans to provide the assays to countries that have detected the virus.

“The monkeypox virus outbreak shows that endemic viruses can rapidly spread to the rest of the world and it’s a warning that new pandemics can emerge and threaten our lives at any time”, “We will continue our efforts to develop products that can accurately diagnose any virus to help prevent new infectious diseases from taking hold and becoming a pandemic.”

Dr. Jong-Yoon Chun, CEO of Seegene

Next Post

Why Healthcare Organizations Should Begin Their Zero-Trust Implementations with Identity

Remote work, virtual care technology and the proliferation of mobile devices for clinician workflows and Internet of Medical Things devices for patient care are increasing the attack surface for healthcare organizations. Some organizations can have as many as 10,000 medical devices within their environments. Patient data is some of the […]